Reported Outcomes


As part of providing exemplary healthcare service to our patients, Harvest Medicine tracks patient progress corresponding to each particular condition. When patients return to our clinic for their medical cannabis follow-up appointments, we ask them to answer two simple questions: “Has medical cannabis met your expectations as part of your treatment plan” and “How has medical cannabis impacted your quality of life?” Patient answers are tracked unique to each condition.






Conditions – Overall

Conditions – Overall

As part of providing exemplary healthcare service to our patients, Harvest Medicine tracks patient progress corresponding to each particular condition. When patients return to our clinic for their medical cannabis follow-up appointments, we ask them to answer two simple questions: “Has medical cannabis met your expectations as part of your treatment plan” and “How has… ...
Conditions – Irritable Bowel Syndrome

Conditions – Irritable Bowel Syndrome

Irritable Bowel Syndrome – Learn More: Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., and Battista, G. (2013, May). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochemical Pharmacology, 85(9), 1306-1316. Retrieved from http://www.sciencedirect.com/science/article/pii/S0006295213000543. Di Carlo, G., and Izzo, A.A. (2003, January). Cannabinoids for gastrointestinal diseases: potential… ...
Conditions – Insomnia

Conditions – Insomnia

Insomnia – Learn More: Calik, M.W., Radulovacki, M., and Carley, D.W. (2014, January 1). Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat. Respiratory Physiology & Neurobiology, 190, 20-24. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880550/. Cousens, K., and DiMascio, A. (1973). (−)δ9 THC as an hypnotic. Psychopharmacologia, 33, 355-364. Retrieved from http://link.springer.com/article/10.1007/BF00437513. Dahl, R.E., Scher, M.S., Williamson, D.E., Robles, N.,… ...
Conditions – Fibromyalgia

Conditions – Fibromyalgia

Fibromyalgia – Learn More: Chiari malformation and syringomyelia. (n.d.). Mayo Clinic. Retrieved from http://www.mayoclinic.org/medical-professionals/clinical-updates/neurosciences/chiari-malformation-syringomyelia. de Souza Nascimento, S., Desantana, J.M., Nampo, F.K., Ribeiro, E.A., da Silva, D.L., Araujo-Junior, J.X., da Silva Almeida, J.R., Bonjardim, L.R., de Souza Araujo, A.A., and Quintans-Junior, L.J. (2013). Efficacy and safety of medicinal plants or related natural products for fibromyalgia: a systematic… ...
Conditions – Depression

Conditions – Depression

Depression – Learn More: Anderson, D.M., Rees, D.I., and Sabia, J.J. (2012, January 7). High on Life? Medical Marijuana Laws and Suicide. Cato Institute, 17. Retrieved from http://object.cato.org/sites/cato.org/files/pubs/pdf/research_brief_17.pdf. Ashton, C.H., and Moore, P.B. (2011, October). Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatrica Scandinavica, 124(4), 250-61. Retrieved from http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.2011.01687.x/full. Bricker, J.B., Russo, J., Stein, M.B., Sherbourne, C.,… ...
Conditions – Pain

Conditions – Pain

Pain – Learn More: About the Epidemic. (n.d.). U.S. Department of Health & Human Services. Retrieved from https://www.hhs.gov/opioids/about-the-epidemic/. Abrams, D.I., Couey, P., Shade, S.B., Kelly, M.E., and Benowitz, N.L. (2011, December). Cannabinoid–Opioid Interaction in Chronic Pain. Clinical Pharmacology & Therapeutics, 90(6), 844-51. Retrieved from http://onlinelibrary.wiley.com/wol1/doi/10.1038/clpt.2011.188/full. Borgelt, L.M., Franson, K.L., Nussbaum, A.M., Wang, G.S. (2013, February). The pharmacologic and… ...
Conditions – Anxiety

Conditions – Anxiety

Anxiety – Learn More: Anxiety & Panic Disorders Health Center: Anxiety Disorders. (n.d.). WebMD. Retrieved from http://www.webmd.com/anxiety-panic/guide/mental-health-anxiety-disorders. Anxiety Disorders. (2015, May). National Institute of Mental Health. Retrieved from http://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml. Bluett, R.J., Gamble-George, J.C., Hermanson, D.J., Hartley, N.D., Marnett, L.J., and Patel, S. (2014). Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Translational Psychiatry, 4(7), e408. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119220/. García-Gutiérrez,… ...